Acotiamide hydrochloride
| Title | Journal |
|---|---|
| Acotiamide, a novel gastroprokinetic for the treatment of patients with functional dyspepsia: postprandial distress syndrome. | Expert review of gastroenterology & hepatology 20120901 |
| A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia. | Gut 20120601 |
| New hope for functional dyspepsia? | Gut 20120601 |
| Therapeutic efficacy of acotiamide in patients with functional dyspepsia based on enhanced postprandial gastric accommodation and emptying: randomized controlled study evaluation by real-time ultrasonography. | Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20120601 |
| Acotiamide, a new orally active acetylcholinesterase inhibitor, stimulates gastrointestinal motor activity in conscious dogs. | Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20120601 |
| Mechanism for distribution of acotiamide, a novel gastroprokinetic agent for the treatment of functional dyspepsia, in rat stomach. | Journal of pharmaceutical sciences 20111101 |
| Acotiamide hydrochloride (Z-338) enhances gastric motility and emptying by inhibiting acetylcholinesterase activity in rats. | European journal of pharmacology 20110901 |
| Acotiamide (Z-338, YM443), a new drug for the treatment of functional dyspepsia. | Expert opinion on investigational drugs 20110501 |
| Acotiamide hydrochloride (Z-338), a new selective acetylcholinesterase inhibitor, enhances gastric motility without prolonging QT interval in dogs: comparison with cisapride, itopride, and mosapride. | The Journal of pharmacology and experimental therapeutics 20110301 |
| A long-term study of acotiamide in patients with functional dyspepsia: results from an open-label phase III trial in Japan on efficacy, safety and pattern of administration. | Digestion 20110101 |
| Clinical trial: dose-dependent therapeutic efficacy of acotiamide hydrochloride (Z-338) in patients with functional dyspepsia - 100 mg t.i.d. is an optimal dosage. | Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20100601 |
| Acotiamide (Z-338) as a possible candidate for the treatment of functional dyspepsia. | Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20100601 |
| Effects of Z-338, a novel gastroprokinetic agent, on the actions of excitatory and inhibitory neurotransmitters on neurons in area postrema. | Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi 20100101 |
| A dose-ranging, placebo-controlled, pilot trial of Acotiamide in patients with functional dyspepsia. | Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20090301 |
| Acotiamide hydrochloride (Z-338), a novel prokinetic agent, restores delayed gastric emptying and feeding inhibition induced by restraint stress in rats. | Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20080901 |
| Characterization of functional effects of Z-338, a novel gastroprokinetic agent, on the muscarinic M1, M2, and M3 receptors expressed in Xenopus oocytes. | European journal of pharmacology 20041128 |
| Drug-drug interactions of Z-338, a novel gastroprokinetic agent, with terfenadine, comparison with cisapride, and involvement of UGT1A9 and 1A8 in the human metabolism of Z-338. | European journal of pharmacology 20040823 |
| Z-338. Zeria/Yamanouchi. | Current opinion in investigational drugs (London, England : 2000) 20040701 |
| Possible involvement of M5 muscarinic receptor in the enhancing actions of the novel gastroprokinetic agent Z-338 on nifedipine-sensitive voltage-dependent Ca2+ currents in guinea pig stomach. | Japanese journal of pharmacology 20020801 |
| An electrophysiological study of muscarinic and nicotinic receptors of rat paratracheal ganglion neurons and their inhibition by Z-338. | British journal of pharmacology 20020301 |
| LC determination of Z-338, novel gastroprokinetic agent in dog plasma by SCX solid phase extraction. | Journal of pharmaceutical and biomedical analysis 20010601 |